1. Home
  2. IPHA vs ESP Comparison

IPHA vs ESP Comparison

Compare IPHA & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • ESP
  • Stock Information
  • Founded
  • IPHA 1999
  • ESP 1928
  • Country
  • IPHA France
  • ESP United States
  • Employees
  • IPHA N/A
  • ESP N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • IPHA Health Care
  • ESP Technology
  • Exchange
  • IPHA Nasdaq
  • ESP Nasdaq
  • Market Cap
  • IPHA 160.1M
  • ESP 148.8M
  • IPO Year
  • IPHA 2019
  • ESP N/A
  • Fundamental
  • Price
  • IPHA $1.82
  • ESP $38.96
  • Analyst Decision
  • IPHA Strong Buy
  • ESP
  • Analyst Count
  • IPHA 3
  • ESP 0
  • Target Price
  • IPHA $5.00
  • ESP N/A
  • AVG Volume (30 Days)
  • IPHA 572.8K
  • ESP 16.0K
  • Earning Date
  • IPHA 09-17-2025
  • ESP 11-12-2025
  • Dividend Yield
  • IPHA N/A
  • ESP 2.59%
  • EPS Growth
  • IPHA N/A
  • ESP 28.72
  • EPS
  • IPHA N/A
  • ESP 3.16
  • Revenue
  • IPHA $14,839,695.00
  • ESP $42,600,530.00
  • Revenue This Year
  • IPHA $22.29
  • ESP N/A
  • Revenue Next Year
  • IPHA $43.84
  • ESP N/A
  • P/E Ratio
  • IPHA N/A
  • ESP $12.21
  • Revenue Growth
  • IPHA N/A
  • ESP 4.90
  • 52 Week Low
  • IPHA $1.41
  • ESP $24.85
  • 52 Week High
  • IPHA $3.51
  • ESP $55.00
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 42.84
  • ESP 52.01
  • Support Level
  • IPHA $1.73
  • ESP $37.12
  • Resistance Level
  • IPHA $1.86
  • ESP $39.45
  • Average True Range (ATR)
  • IPHA 0.12
  • ESP 1.34
  • MACD
  • IPHA -0.02
  • ESP 0.26
  • Stochastic Oscillator
  • IPHA 11.51
  • ESP 68.03

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: